Dynavax Technologies Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Dynavax Technologies Corporation income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue277.25232.28722.68439.4440.2535.228.20
Cost of Revenue49.45102.48308.75205.8040.0219.3921.80
Gross Profit227.80129.81413.93233.640.2315.83-13.60
Operating Expenses
Research & Development61.5554.8946.6032.2328.6162.3374.95
Selling, General & Administrative170.37147.94123.7292.4271.5574.9964.77
Operating Expenses231.92160.26123.7292.4274.05137.32139.72
Operating Income-4.12-30.45290.21141.22-73.82-134.84-153.32
Other Income/Expense
Interest Income36.4631.997.910.141.260.003.83
Interest Expense6.79-6.76-6.73-11.18-19.060.009.34
Other Income/Expense5.31-0.051.81-49.333.936.77-0.07
Income
Income Before Tax30.86-4.37294.3077.52-75.24-152.60-158.90
Income Tax Expense3.552.021.140.81-3.19-3.150.00
Net Income27.31-6.39293.1676.71-75.24-152.60-158.90
Net Income - Continuous Operations27.31-6.39293.1676.710.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.00
EBITDA45.70-26.11294.02145.52-67.04-115.59-135.08
EBIT37.65-30.45290.21141.22-73.82-135.62-149.56
Depreciation & Amortization8.054.343.814.306.778.900.00
Earnings Per Share
Basic EPS--2.001.00-1.00-2.00-3.00
Diluted EPS--2.001.00-1.00-2.00-3.00
Basic Shares Outstanding130.05128.73126.40116.26100.7572.0262.36
Diluted Shares Outstanding133.34128.73150.80133.01101.500.0062.36